Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

YouTube

Cardiovascular Research Highlights and EMPA-KIDNEY Trial Analysis - 2022

Yale Cardiovascular Medicine Grand Rounds via YouTube

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Join a comprehensive Yale Cardiovascular Medicine Grand Rounds session exploring the key findings and developments from the 2022 American Heart Association (AHA) Scientific Sessions. Delve into detailed analyses of multiple cohort studies, examining cardiovascular and non-cardiovascular mortality rates, with particular attention to major limitations and follow-up data spanning 3.2 years. Examine cumulative event rates of cardiovascular death, explore the implications of Multi-Vessel Disease (MVD), and understand the significant outcomes of the EMPA-KIDNEY trial. Learn about patient enrollment strategies, study methodologies, and pre-defined subgroup analyses while gaining insights into the strengths, limitations, and future directions of cardiovascular research presented at this prestigious scientific meeting.

Syllabus

Intro
Studies
Methods
Safety
Background
Cohort 1
Cohort 2
Major limitations
Original Follow-up 3.2 Years
Cumulative event rate of cardiovascular death
Non-Cardiovascular Death based on MVD
Key Points
Secondary outcomes
Patient enrollment
Conclusions from the EMPA-KIDNEY trial
Study design
Study outcomes
Pre-defined subgroup analysis
Limitations and strengths
Future directions

Taught by

Yale Cardiovascular Medicine Grand Rounds

Reviews

Start your review of Cardiovascular Research Highlights and EMPA-KIDNEY Trial Analysis - 2022

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.